WHO ICTRP trial

PHARMACOKINETIC COMPARISON OF ADVATE rAHF-PFM WITH RECOMBINATE rAHF IN PATIENTS…

EUCTR2007-004834-18-DE · EU Clinical Trials Register · Not Recruiting

Key facts

Trial ID EUCTR2007-004834-18-DE
Public title PHARMACOKINETIC COMPARISON OF ADVATE rAHF-PFM WITH RECOMBINATE rAHF IN PATIENTS WITH SEVERE HEMOPHILIA A: A PHASE IV, PROSPECTIVE, RANDOMIZED, CONTROLLED, CROSS-OVER, SINGLE CENTER STUDY - Advate rAHF-PFM versus Recombinate rAHF
Scientific title PHARMACOKINETIC COMPARISON OF ADVATE rAHF-PFM WITH RECOMBINATE rAHF IN PATIENTS WITH SEVERE HEMOPHILIA A: A PHASE IV, PROSPECTIVE, RANDOMIZED, CONTROLLED, CROSS-OVER, SINGLE CENTER STUDY - Advate rAHF-PFM versus Recombinate rAHF
Primary sponsor Baxter Innovations GmbH
Registry EU Clinical Trials Register
Recruitment status Not Recruiting
Study type Interventional clinical trial of medicinal product
Countries Germany
Conditions The objective of this study is to further evaluate observations of decreased efficacy in subjects having been switched to Advate rAHF-PFM from Recombinate rAHF by comparing the pharmacokinetic parameters of the two products in previously…
Interventions Trade Name: Advate Product Name: Advate Pharmaceutical Form: Powder and solvent for suspension for injection INN or Proposed INN: Octocog alfa Other descriptive name: recombinant coagulation factor VIII Concentration unit: IU international…
Registration date Nov 30, 2007
Secondary IDs 060601
Registry page clinicaltrialsregister.eu

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations